An ACT1 Mutation Selectively Abolishes Interleukin-17 Responses in Humans With Chronic Mucocutaneous Candidiasis
Immunity - United States
doi 10.1016/j.immuni.2013.09.002
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2013
Authors
Publisher
Elsevier BV